Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global changes in gene expression and splicing in alcoholic liver disease.

Scientific reports·2026
Same author

The Impact of Load per Kilogram of Body Mass Carried on Dynamic Postural Stability in Firefighter Cadets.

Journal of strength and conditioning research·2026
Same author

Editorial: Genome-wide molecular mechanisms of substance use disorders.

Frontiers in psychiatry·2024
Same author

Investigation into the use of novel pretreatments in the fermentation of Alaria esculenta by Lactiplantibacillus plantarum and kombucha SCOBY.

Food chemistry·2024
Same author

Alcohol use disorder conceptualizations and diagnoses reflect their sociopolitical context.

Addiction research & theory·2023
Same author

Risk for Suicidal Behavior After Psychiatric Hospitalization Among Sexual and Gender Minority Patients.

JAMA network open·2023
Same journal

Validating the Factor Structure of the Fujisawa Social Capital Scale (FSCS) Among Community-Dwelling Older Adults Participating in "Kayoi-no-ba": The Gunma Aging Cohort Study.

Social work in public health·2026
Same journal

Silent Scars: Trauma in Communities.

Social work in public health·2026
Same journal

They are Sending Us to Our Early Graves: Older People's Accounts of Elder Abuse in Uganda.

Social work in public health·2026
Same journal

Examining Missed Healthcare Appointments (No-Shows) in a Rural-Serving Federally Qualified Community Health Center in the United States.

Social work in public health·2026
Same journal

Emotional Intelligence in Health Contexts: A 'Social Work Gene' Model Analysis.

Social work in public health·2026
Same journal

Equity and Resilience in Higher Education: An Examination of Environmental Injustices Affecting College Students from Marginalized Populations Amid Climate Crises.

Social work in public health·2026
See all related articles

Related Experiment Video

Updated: May 10, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Medications for substance use disorders.

Antoine B Douaihy1, Thomas M Kelly, Carl Sullivan

  • 1Department of Psychiatry, Western Psychiatric Institute & Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. douaihya@upmc.edu

Social Work in Public Health
|June 5, 2013
PubMed
Summary
This summary is machine-generated.

This review covers medications for substance use disorders, highlighting nicotine replacement for tobacco, naltrexone/acamprosate/disulfiram for alcohol, and methadone/buprenorphine for opiate use disorders.

More Related Videos

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

Related Experiment Videos

Last Updated: May 10, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

Area of Science:

  • Pharmacology
  • Addiction Medicine
  • Neuroscience

Background:

  • Substance use disorders (SUDs) represent a significant global health challenge.
  • Effective pharmacotherapeutic options are crucial for managing SUDs.
  • Advances in medication development offer new hope for treatment.

Purpose of the Study:

  • To review current pharmacotherapeutic agents for SUDs.
  • To discuss recent advancements in medication development for various addictions.
  • To explore the integration of behavioral and pharmacological treatments.

Main Methods:

  • Literature review of existing pharmacotherapeutic agents for SUDs.
  • Examination of recent research on novel medication development for SUDs.
  • Discussion of treatment adherence and combined intervention strategies.

Main Results:

  • Nicotine replacement therapies are effective for tobacco cessation.
  • Naltrexone, acamprosate, and disulfiram aid in reducing alcohol use.
  • Methadone and buprenorphine are effective agonist therapies for opiate use disorders.

Conclusions:

  • Pharmacotherapy plays a vital role in managing substance use disorders.
  • Ongoing research promises new treatments for conditions like stimulant addiction.
  • Integrating medication with behavioral therapies enhances treatment outcomes.